ClinConnect ClinConnect Logo
Search / Trial NCT06099717

Clinical Performance of Dual-cantilevered Single-implant Bridge

Launched by UNIVERSITY OF BERN · Oct 19, 2023

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Dental Implant

ClinConnect Summary

This clinical trial is studying a new type of dental bridge called the dual-cantilevered single-implant bridge, or T-Bridge. This dental work is designed to support three missing teeth in a row in the back of the mouth. The study will look at how well this bridge works and how long it lasts, using a special material called monolithic zirconia attached to a titanium base.

To participate, you need to be at least 20 years old and willing to sign consent for the study. You should have three missing adjacent teeth, a gap of 21-24 mm, and enough space in your mouth for the dental implant. Certain health conditions, including issues that affect healing or mental health challenges, may prevent you from joining. If you decide to participate, you can expect regular follow-ups to monitor the success of the implant and ensure everything is going well. This trial is currently recruiting participants of all genders, particularly those in the age range of 65 to 74 years.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 20 years
  • Willingness to sign an informed consent and participate in the study
  • Three missing adjacent teeth in the posterior site.
  • Tooth gap of 21-24 mm.
  • Presence of natural or artificial opposing dentition
  • Sufficient vertical interocclusal space of an implant restoration (7mm)
  • Sufficient ridge height to place an implant of 10mm in length
  • Sufficient ridge width for the placement of a 4.1mm diameter implant. Simultaneous GBR to achieve a width of 6.5mm will be included.
  • Exclusion Criteria:
  • Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance with the protocol
  • Any disorder that would interfere with wound healing or represent a contraindication for implant surgery, such as but not limited to uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates.
  • Pregnancy or lactation
  • Heavy smoking habit with ≥ 10 cig/d
  • Severe bruxism or clenching habits, presence of oro-facial pain
  • Insufficient ridge width/height for the study implant

About University Of Bern

The University of Bern, a leading research institution in Switzerland, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university fosters an environment where scientific inquiry and clinical application intersect. Its commitment to ethical standards and patient safety ensures that all trials are conducted with the highest integrity, striving to contribute valuable insights to the global medical community. The University of Bern actively engages in diverse therapeutic areas, aiming to translate research findings into tangible health solutions.

Locations

Goiania, Goias, Brazil

Patients applied

CW

TN

AG

ER

4 patients applied

Trial Officials

Martin Schimmel, Prof

Study Chair

University of Bern

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported